Aarti Industries Ltd, the leading manufacturer of basic and speciality chemicals and pharmaceuticals, has posted 536 per cent jump in net profit at Rs 33.2 crore in the first quarter of the current fiscal as compared to Rs 5.2 crore in the corresponding period of last year.
Turnover of the company grew 85 per cent to Rs 361.7 crore in the Q1, 2009 in comparison with Rs 194.3 crore in Q1, 2008.
Similarly, Earnings Before Interest, Taxes, Depreciation and Amortisation (EBIDTA) also increased by over 215 per cent to Rs 65.5 crore in the first quarter of the current fiscal in comparison with Rs 20.8 crore in the same period last year.
With the increase in the volumes and margins, the quarter on quarter performances of the company had soared consistently since past three quarters. Additional capacities being commissioned by the company coupled with the process innovation and development would result in increase in the topline and bottomline numbers in future.
The company had also got the approval from the United States Food & Drug Administration (USFDA) for its Active Pharmaceutical Ingredients (API) facility at Tarapur. It also expects to increase its Contract Research & Manufacturing activities (CRAMs) in future.
